Acquired Tolerance of Hepatocellular Carcinoma Cells to Selenium Deficiency: A Selective Survival Mechanism? by Irmak, M.B. et al.
[CANCER RESEARCH 63, 6707–6715, October 15, 2003]
Acquired Tolerance of Hepatocellular Carcinoma Cells to Selenium Deficiency:
A Selective Survival Mechanism?1
Meliha Burcu Irmak, Gulayse Ince,2 Mehmet Ozturk, and Rengul Cetin-Atalay3
Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, 06533 Ankara, Turkey
ABSTRACT
Selenium is essential to human health, and its deficiency is associated
with different diseases including liver necrosis. Selenium is protective
against viral hepatitis and hepatocellular carcinoma (HCC). The under-
lying molecular mechanisms of selenium effects are not well known. In this
study, in vitro response of HCC-derived cell lines to selenium deficiency is
examined alone or in conjunction with Vitamin E and copper/zinc. Here,
we show that in vitro selenium deficiency in a subset of HCC-derived cell
lines causes oxidative stress and cytochrome c release with subsequent cell
death by apoptosis. The oxidative stress and consequent cell death induced
by selenium deficiency on these cells are reverted by the antioxidant effect
of Vitamin E. However, most HCC cell lines (10 of 13) tolerate selenium
deficiency. Consequently, they escape apoptosis. Moreover, nine of these
tolerant cell lines have integrated hepatitis B Virus (HBV) DNA in their
genomes, and some display p53-249 mutation, indicating past exposure to
HBV or aflatoxins, established factors for oxidative stress and cancer risk
in liver. An HBV-transfected clone (2.2.15) of the sensitive HepG2 cell line
has gained tolerance to selenium deficiency. Our findings indicate that
selenium deficiency induces apoptosis in some “hepatocyte-like” cells.
However, most HCC cells, particularly HBV-related ones, tolerate sele-
nium deficiency and escape its deadly consequences. Thus, as demon-
strated by the gain of survival capacity of apoptosis-sensitive cell lines
with Vitamin E, such malignant cells have acquired a selective survival
advantage that is prominent under selenium-deficient and oxidative-stress
conditions.
INTRODUCTION
Selenium is an essential trace element (1), and the necessity of
selenium as a dietary factor has been known for almost 50 years. Low
selenium status may contribute to the etiology of different disease
conditions such as loss of immunocompetence, viral infections, re-
productive deficiencies, thyroid and cardiovascular diseases, and pan-
creatitis (2). In addition, epidemiological studies have suggested an
inverse relationship between selenium levels and different cancers
(3–7). Selenium is the protective factor against dietary “necrotic” liver
degeneration in rats, based on seminal observations by Schwarz and
Foltz (8). In humans, severe selenium deficiency was recognized
initially in endemic Keshan and Keshan-Beck diseases (2). Selenium
is considered to play an indirect antioxidant role as an essential
constituent of a selenoprotein, namely Gpx,4 in elimination of cellular
ROS. Cytosolic or classical Gpx, Gpx-1, is considered the most
critical enzyme for the protective effects of selenium. The major
cellular site of ROS production is thought to be the mitochondria.
During mitochondrial respiration about 2% of the oxygen fails to
undergo complete reduction to H2O and is released as superoxide
radical (9–11). Superoxide radicals are converted to H2O2 by super-
oxide dismutase enzyme (12, 13). H2O2 in turn is reduced to H2O by
Gpx, which catalyzes the reduction of hydroperoxides as well as H2O2
to H2O and alcohols, which prevents the formation of highly toxic free
radicals (1) and which is accompanied by the oxidation of GSH to
GSGS (9, 14). Thus Gpx-1 is protective against oxidative stress, both
in vitro and in vivo (15–17).
Decreased selenium levels were found in HBV and hepatitis C
infection (6, 18), intrahepatic cholestasis (19), and post-viral or alco-
holic cirrhosis (20). A recent epidemiological study among chronic
carriers of HBV and/or hepatitis C showed that mean plasma selenium
levels were significantly lower in patients who developed HCC than
in the healthy HbsAg-positive controls, demonstrating an inverse
correlation between plasma selenium levels and HCC (see Ref. 6). In
addition, selenium supplementation showed a protective effect against
HBV infection and HCC (18). These reports clearly indicate that
selenium deficiency is associated with severe liver disease and that
dietary selenium is protective against HCC.
Despite a large body of evidence linking selenium deficiency to
different hepatic disease conditions, cell fate changes consequent to
selenium deficiency and mechanisms of protective effects of selenium
against HCC and other cancers are poorly known. Here, we report on
an in vitro response of HCC-derived cell lines to selenium deficiency.
We provide experimental evidence that selenium deficiency leads to
apoptosis in some HCC-derived cell lines with or without copper/zinc.
However, Vitamin E has a protective antioxidant effect against cell
death in the absence of selenium. This apoptotic effect may represent
the dietary necrotic liver degeneration, terminology often used to
explain hepatic damage observed in animals and people under sele-
nium deficiency. In this study, we also show that the apoptotic
response to selenium deficiency is caused by oxidative stress. On the
other hand, most HCC-derived cell lines tolerated selenium deficiency
as well as oxidative stress-inducing conditions. On the basis of these
in vitro observations, we hypothesize that selenium deficiency in liver
confers growth advantage to malignant tumor cells, because they
appear to adapt themselves to a selenium-deficient cellular environ-
ment. Finally, our observations also indicate that the tolerance of HCC
cells to selenium deficiency and oxidative stress treatment is associ-
ated with the presence of HBV genome sequences in their host
genomes, suggesting a possible link between HBV and adaptation to
selenium deficiency.
MATERIALS AND METHODS
Cell Culture. Human hepatocellular cancer-derived cell lines (n  14)
were cultured routinely at 37°C under 5% CO2 in the standard medium (2 mM
L-glutamine, 0.1 mM nonessential amino acids, 100 units/ml penicillin, 100
g/ml streptomycin in copper/zinc-free DMEM or HAM’s medium that con-
tains 10 M copper and 3 mM zinc), supplemented with 10% FCS (BioChrom).
To study the effects of selenium deficiency, cells were grown either in
selenium-deficient medium (standard medium with 0.01% FCS) or in a sele-
nium-supplemented standard medium with 0.01% FCS and 0.1 M sodium
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selenite (Sigma) and 100 M Vitamin E (D--tocopherol, Grandpherol; Ilsan
Iltas A.S.) in 0.25% DMSO. For these experiments, cells were plated initially
in a standard medium with 10% FCS, using 6-well tissue plates, or alterna-
tively in 100-mm tissue culture dishes. The next day, after cells were washed
three times with PBS, the culture medium was replaced by either a selenium-
deficient or a selenium-supplemented medium. Cells were maintained in these
media for up to 10 days by refeeding with fresh media every 2 days.
Detection of Apoptosis. Cells were seeded on autoclave-sterilized cover-
slips in 6-well plates. After overnight culture in a standard medium with 10%
FCS, cells were exposed to a selenium-deficient or a selenium-supplemented
medium as described above, for up to 10 days. At times indicated in the
legends of Figs. 1–9, the following tests were performed. Cell morphology
changes were observed under inverted microscope. To determine nuclear
condensation by Hoechst 33258 (Sigma) staining, coverslips were washed in
ice-cold PBS twice and were fixed in 1 ml of 90% (v/v) cold ethanol for 10 min
and then incubated with 3 g/ml Hoechst 33258 for 5 min in the dark.
Coverslips were then rinsed with distilled water, mounted on glass microscopic
slides in 50% glycerol, and examined under fluorescent microscope (Axio-
skop, Zeiss). TUNEL assay was performed using In Situ Cell Death Detection
kit (Roche), according to the manufacturer’s recommendations. The Annexin
V assay was performed using Annexin V-PE reagent (PharMingen) on live
cells according to the manufacturer’s recommendations, and the cells were
fixed in ethanol before examination under fluorescent microscope. For NAPO
assay (21) cells were fixed with 4% paraformaldehyde for 20 min at room
temperature and then were rinsed and permeabilized with 0.1% Triton X-100
and 0.1% sodium-citrate in PBS on ice for 10 min. After the washing with
PBS-T, cells were blocked with 3% BSA in PBS-T for 1 h at room temperature
and then were incubated with anti-NAPO monoclonal antibodies for 1 h at
room temperature. After being washed with PBS-T, the cells were incubated
with FITC-conjugated antimouse secondary antibody (DAKO) for 1 h at room
temperature, washed three times with PBS-T, and then mounted. Samples were
analyzed by fluorescence microscopy.
Assay for Gpx Activity. The enzymatic activity of Gpx was measured on
a native polyacrylamide gel, as described by Sun et al. (22), with minor
modifications. This assay was reported to be specific for the visualization of
the Gpx activity bands without interference from catalase and other peroxi-
dases when the gel was soaked into GSH (Sigma) with concentrations higher
than 1 mM (22). Briefly, cells were grown under selenium-supplemented or
selenium-deficient media for 96 h. Cell pellets were obtained by scraping,
stored overnight at 20°C, and lysed in a buffer containing 50 mM Tris-HCl
(pH 8.0), 300 mM NaCl, and 1 (v/v) Complete Protease Inhibitor Cocktail
(Roche) for 30 min on wet ice. Clear supernatants were obtained by centrif-
ugation at 13,000 rpm for 15 min at 4°C. Freshly collected mouse liver tissue
homogenate was used as a positive control. Equal quantities of proteins from
cell lysate (50 g) were separated by native gel electrophoresis. Wet gels were
then washed three times in a buffer composed of 50 mM Tris-HCl (pH 8.0) and
1.5 mM GSH (buffer 1) and then washed in buffer 1 containing 0.003% H2O2.
After rinsing with distilled water, the gel was stained in a reagent prepared by
mixing equal volumes of freshly prepared 2% (w/v) solutions of potassium-
ferricyanide and ferric-chloride (Sigma), until a dark green background ap-
peared with yellow enzymatic activity bands.
Detection of HBV Virus DNA by PCR. Genomic DNA was extracted
from cell lines, and the presence of HBV DNA was tested using two sets of
primer pairs to amplify HBs and HBx gene sequences, as described previously
(23). A plasmid containing head-to-tail dimer of HBV genome was used as a
positive control (24).
In Vitro Cell Growth Assay. Cells (60,000) were plated into 6-well plates
and were grown overnight in a control medium. The following day, cells were
washed with PBS, fed with a selenium-supplemented or selenium-deficient
medium, and further grown for 10 days. Attached cells were then stained with
Giemsa (Sigma), and photographed.
Western Blot. Cells were lysed with a NP40 lysis buffer containing 150
mM NaCl, 50 mM Tris-HCl (pH 8.0), and 1% NP40 (Igepal CA-630, Sigma);
1 (v/v) Complete Protease Inhibitor Cocktail was added freshly. Briefly,
cells were scraped with ice-cold PBS on ice, centrifuged at 13,000 rpm for 10
min, resuspended in four volumes of a NP40 lysis buffer, and incubated on ice
for 30 min. The lysate was centrifuged at 13,000 rpm for 10 min at 4°C, and
soluble proteins were quantified by Bradford assay (25) in supernatants.
Proteins were separated by SDS-PAGE (8%) and were transferred onto poly-
vinylidene difluoride (Roche) membrane. The membrane was blocked 1 h at
room temperature with 5% nonfat milk in PBS-T and incubated with anti-
PARP monoclonal antibody or AKT polyclonal antibody (Santa Cruz Biotech-
nology) in PBS-T with 2.5% nonfat milk for 1 h at room temperature. The
unbound antibody was washed four times with PBS-T. The membrane was
incubated with horseradish peroxidase-conjugated secondary antibody
(DAKO) in PBS-T with 2.5% for 1 h at room temperature and washed, and
then detected by Enhanced ChemiLuminescence (ECL) detection kit (Amer-
sham-Pharmacia). Equal loading control was determined by reprobing the
same membranes with anti-cytokeratin 18 monoclonal antibody JAR1 3 (kind-
ly provided by D. Bellet, Institute Gustave Roussy).
Immunofluorescence Assay for Cytochrome c Release. Cytoplasmic cy-
tochrome c was tested by immunofluorescence staining, as described by
Achenbach et al. (26). Cells were grown on coverslips and fixed with 4%
paraformaldehyde for 30 min at room temperature and then were rinsed and
permeabilized in ice-cold acetone for 10 min. After washing with PBS, the
cells were blocked with 3% BSA in PBS-T for 1 h at 37°C and then were
incubated with anti-cytochrome c monoclonal antibody (PharMingen) over-
night at 4°C. After washing with PBS-T, the cells were incubated with
FITC-conjugated antimouse secondary antibody (DAKO) for 1 h at room
temperature, washed three times with PBS-T, then mounted. Samples were
analyzed by fluorescence microscopy. When released from mitochondria,
cytochrome c gives a diffused and more intense fluorescent signal (26).
Detection of Oxidative Stress. Oxidative stress was detected by DCF
assay (27). The nonfluorescent DCFH-DA (Sigma) is a cell-permeable com-
pound that can enter into cells, in which it is deacetylated and entrapped as
DCFH, the oxidation of which by ROS (hydroxyl radical, superoxide, hydro-
gen peroxide . . . ) produces a highly fluorescent product, DCF, that can be
visualized under a fluorescent microscope. Cells were cultured for 96 h,
washed with PBS three times, and incubated for 15 min at 37°C in PBS
containing 10 mM HEPES (pH 7.5), 10 mM glucose, and 1 M DCFH-DA.
Cells were washed again three times with PBS, mounted directly on a slide,
and examined under a fluorescent microscope.
Hydrogen Peroxide Assay. Huh-7, Hep3B-TR, HepG2, and HepG2–
2.2.15 cells were cultured under selenium-supplemented and selenium-defi-
cient conditions for 3 days. On the 3rd day of the culture, H2O2 (0, 25, 50, 100,
and 200 M) was added to the cell culture medium. Four h later, the live cells
under oxidative stress were counted by DCF staining under inverted micro-
scope, and the apoptotic cells were counted by Hoechst 33258 staining under
a fluorescent microscope.
RESULTS
Experimental Induction of in Vitro Selenium Deficiency. He-
patic selenium deficiency induced in vivo by feeding experimental
animals is accompanied by a decrease in antioxidant selenoproteins,
including Gpx and subsequent hepatic necrosis because of oxidative
stress (8). It has also been reported that human hepatoma cells, when
cultivated in vitro in a selenium-deficient medium, display a similar
loss in Gpx activity (28), suggesting that such cells can serve as an in
vitro model to study hepatocellular response to selenium deficiency. It
has also been reported that Huh7 hepatoma cells can be maintained
and expanded in a chemically defined serum-free culture medium,
provided that it is supplemented with selenium (29). On the basis of
these observations, we first studied the response of Huh7 cells to
selenium deficiency by maintaining them in a selenium-deficient
culture medium for up to 8 days. The cellular response to selenium
deficiency was first assessed by testing cellular Gpx activity, using a
specific in situ staining technique (22). Huh7 cells display positive
Gpx activity when grown in standard culture medium that contains
10% FCS (data not shown). A similar positive Gpx activity was
detected when the DMEM culture was depleted of FCS (0.1%), but
complemented with selenium (0.1 M), as shown in Fig. 1A. As
expected, the removal of selenium from the latter provoked the loss of
Gpx activity in these cells, which was no longer detectable after 4
days of culture (Fig. 1A).
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The loss of Gpx activity in selenium-deficient cells impairs their
antioxidant response, leading to an accumulation of ROS, which can
be detected at the cellular level by the oxidation of nonfluorescent
DCFH-DA into a fluorescent form (27, 30). As shown in Fig. 1B,
Huh7 cell line, when cultivated in selenium-deficient HAM’s culture
medium, which contains copper/zinc, or in DMEM culture (data not
shown), displayed many fluorescent cells on examination under flu-
orescence microscopy, indicating the accumulation of ROS in such
cells. The fact that this response is attributable to selenium deficiency
alone and in conjunction with copper/zinc was confirmed by the
absence of fluorescent cells in the same cell line that was cultivated in
selenium-supplemented medium (data not shown). Taken together,
these observations indicated that selenium-deficient Huh7 cells dis-
play a drop in their Gpx activity, accompanied by an intracellular
accumulation of ROS, in a way quite similar to liver cells of animals
subjected to in vivo selenium deficiency (31).
Impaired Survival of Selenium-Deficient Huh7 Cells Attribut-
able to Apoptotic Cell Death. Next, we studied the growth of Huh7
cells under selenium-deficient conditions. Huh7 cells were examined
under light microscopy at different intervals between 1 and 8 days.
Cells showed no detectable change in cell morphology during the first
48 h of culture. However, starting at 72 h, individual Huh7 cells
displayed morphological changes reminiscent of apoptotic cell death,
with swelling and nuclear condensation (Fig. 2A). The cell death was
time dependent and progressive, which was affecting more that 70%
of cells at day 7, under selenium deficiency (Fig. 2). These changes
were observed only in selenium-deficient cells, but not in those
cultivated in the selenium-complemented medium (Fig. 2). Thus, the
complementation of culture medium with 0.1 M selenium alone or in
addition to copper/zinc was sufficient to prevent not only oxidative
stress but also the death of Huh7 cells.
Next, we characterized the nature of death that is observed in Huh7
cells under selenium deficiency. As shown in Fig. 3, selenium-defi-
cient Huh7 cells displayed smaller and condensed nuclei with strong
Hoechst 33258 staining (Fig. 3A, right panels) bearing apoptosis. The
apoptotic cell death was confirmed with three different tests; namely,
TUNEL assay that detects DNA fragmentation (Fig. 3A, top panels)
and Annexin V staining that detects cell membrane changes (data not
shown), as well as by a recently described immunofluorescence tech-
nique (15) detecting the loss of NAPO antigen in apoptotic cells (Fig.
3A, bottom panels). Control Huh7 cells were free of such described
changes (data not shown).
Apoptotic cell death is often accompanied by the release of cyto-
chrome c from the mitochondria (32, 33). Cytoplasmic cytochrome c
triggers a cascade of caspase activation, initiated by the formation of
apoptosome complex with Apaf-1 and caspase 9, ultimately leading to
the activation of caspase 3, which cleaves a set of specific target
proteins, including PARP (34). As shown in Fig. 3B, positive immu-
nostaining for cytoplasmic cytochrome c was detectable among sele-
nium-deficient cells but not among those of the control group. This
indicated that mitochondrial cytochrome c was released into the
cytoplasm of selenium-deficient cells. Fig. 3B clearly demonstrates
that the diffuse cytoplasmic positive staining for cytochrome c corre-
lates perfectly with the nuclear condensation of apoptotic cells, sug-
gesting that cell death is imminent to the release of cytochrome c in
these cells. To test the activation of caspase 3 in selenium-deficient
Huh7 cells indirectly, we analyzed the levels of PARP by Western
blot technique. Selenium-deficient cells were maintained in culture
until more than 90% of the cells displayed apoptotic features, and then
cell lysates were tested. PARP was no longer detectable in apoptotic
Huh7 cells, and this loss appeared to be specific, because there was no
detectable change in the levels of cytokeratin 18 under the same
conditions (Fig. 3C).
The oxidative stress observed under selenium-deficient conditions
triggered an apoptotic response in Huh7 cells. To further explore a
cause-effect relationship among selenium deficiency, oxidative stress,
and subsequent apoptosis, we cultivated Huh7 cells in either a sele-
nium-deficient or a selenium-supplemented medium for 3 days and
Fig. 2. Death of Huh7 cells under selenium deficiency. A, analysis of Huh7 cell growth
under selenium-supplemented (Se) or selenium-deficient (Se) HAM’s medium. Huh7
cells were examined under inverted light microscope on a daily basis, and pictures were
taken at day 3. 100. B, the percentage of death cell nuclei was counted up to 8 days with
Hoechst staining under a fluorescent microscope. Note the abundance of cell death in
Huh7 cells in the selenium-deficient (Se) DMEM cell culture. There is no cell death in
selenium-supplemented (Se) medium. The results are from three separate experiments.
Error bars, SD.
Fig. 1. In vitro response of Huh7 cells to selenium deficiency. Huh7 cells were grown
in selenium-supplemented (Se) or selenium-deficient (Se) conditions. A, in vitro
selenium deficiency was tested by the loss of Gpx activity. At 96 h, cells were solubilized
as described in “Materials and Methods,” and 50 g of soluble proteins from cell lysates
were separated by native PAGE, followed by in situ staining for Gpx with a colorimetric
assay. Mouse liver tissue lysate was used as a positive control. B, analysis of oxidative
stress by oxidant-sensitive fluorescent dye, DCFH-DA. Huh7 cells were cultured under
Se HAM’s medium for 72 h, and then DCF fluorescence was observed under an inverted
fluorescent microscope. The presence of fluorescence indicates that Huh7 cells harbor
oxidative stress (right panel). Inverted light microscopy photographs (left panel) of the
corresponding area of fluorescent photographs of Huh7 cells under Se conditions were
also shown. 200.
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then treated them with increasing doses of hydrogen peroxide. The
cells were left in culture for an additional 4 h, and the ratio of cells
positive for ROS or apoptotic features were calculated. Huh7 cells
cultivated in a selenium-supplemented medium were able to tolerate a
treatment with at least 200 M hydrogen peroxide, with no sign of
oxidative stress or apoptosis; in contrast, selenium-deficient Huh7
cells responded to hydrogen peroxide treatment by a dose-dependent
increase in both oxidative stress and apoptotic cell death responses
(Fig. 4, top panels). As little as 25 M hydrogen peroxide was
sufficient to bring an increase in oxidative stress with concomitant
apoptosis. These responses were dose dependent and paralleled each
other (compare Fig. 4, top left and right panels), strongly suggesting
that selenium deficiency leads to sensitivity to oxidative stress, which
in turn leads to apoptotic cell death.
Taken together, these observations indicate that in vitro selenium
deficiency in Huh7 cells recapitulates hepatocellular injury observed
in experimental animals (31) as well as in humans (loss of Gpx
activity, oxidative stress, and cell death) exposed to selenium defi-
ciency independent of copper/zinc, which are other important ions for
oxidative stress. In addition, we provide experimental evidence that
the cellular injury caused by selenium deficiency occurs in the form of
programmed cell death, at least in vitro. However, epidemiological
studies clearly indicate that selenium deficiency is associated with an
increased risk of HCC development, particularly in patients with
chronic liver disease because of HBV (6). At first glance, our obser-
vations would be against the expectation that selenium deficiency will
favor the expansion of HCC cells, rather than limiting their growth
capacity by apoptotic cell death. Because individual cell lines may
vary in their phenotypic characteristics, we aimed at performing
similar studies in additional HCC cell lines.
Selenium-Deficient Hep3B-TR Cells Tolerate Oxidative Stress
and Resist Apoptosis. It has been reported previously that well-
differentiated human HCC-derived Hep3B cells respond to in vitro
selenium deficiency by a progressive depletion of Gpx transcripts, as
well as by a loss of their Gpx enzymatic activity (28). We reproduced
selenium-deficient conditions for Hep3B-TR cells (35) and tested
their response to H2O2 treatment, as described for Huh7 cells. These
cells displayed extreme tolerance to H2O2 treatment, without any
indication of oxidative stress after exposure to 200 M H2O2, even
under selenium-deficient conditions. As shown in Fig. 4, selenium-
deficient Hep3B-TR cells were more strongly resistant to exogenous
H2O2 treatment than were Huh7 cells. As a consequence of this higher
tolerance, Hep3B-TR cell death was not observed under these condi-
tions (Fig. 4, bottom right panel).
To test whether this tolerance of Hep3B-TR cells was caused by an
unusual ability to maintain selenoprotein activity under our selenium
starvation conditions, we assessed their Gpx activity. Hep3B-TR cells
have lost their Gpx activity after 4 days of selenium starvation (Fig.
5A), similar to what we observed with Huh7 cells (Fig. 1A), and as
reported previously by others (28). Thus, both Huh7 and Hep3B-TR
cells became selenium deficient after 4 days of selenium starvation,
but they differed sharply in their respective responses. Selenium-
Fig. 3. Characterization of Huh7 cell death as apoptosis. Huh7 cells were grown in a
selenium-supplemented (Se) and/or selenium-deficient (Se) medium for 96 h. A,
selenium-deficient Huh7 cells were tested by fluorescent TUNEL in DMEM and NAPO
assays in HAM’s medium. Nuclear DNA was visualized by Hoechst 33258 counterstain-
ing. Apoptotic Huh7 cells display positive TUNEL and negative NAPO staining. B,
demonstration of cytochrome c release under oxidative stress in Huh7 cells by immuno-
staining of intracellular cytochrome c (left panels) selenium-supplemented (Se) or
selenium-deficient (Se) DMEM. Under selenium-supplemented conditions, Huh7 cells
show scattered mitochondrial cytochrome c stain, whereas they show diffuse and more
intense stain under selenium-deficient conditions (white arrows). Notable are the con-
densed nuclei of Huh7 cells that release cytochrome c under selenium-deficient conditions
(right panel). C, immunoblot analysis of PARP protein in DMEM. Selenium deficiency
induces total proteolysis of PARP in apoptosis-sensitive Huh7 cell line when there was
more than 90% apoptosis. On the other hand, Huh7 has intact PARP protein under Se
conditions. Each well was loaded with 10 g of protein in 8% SDS-PAGE. Cytokeratin
18 probing was performed as an equal loading control.
Fig. 4. Dose-dependent association of external oxidative stress
with onset of apoptosis. Huh7 and Hep3B-TR cells were cultured
under Se and Se conditions in DMEM for 72 h and then treated
with the indicated concentrations of H2O2. Four h later, cells under
oxidative stress were counted by fluorescent microscope, and apo-
ptotic cells were counted by Hoechst 33258 staining. With increas-
ing concentrations of H2O2, the percentage of Huh7 cells under
oxidative stress and apoptosis increased accordingly under Se
conditions. On the other hand, Hep3B-TR cells did not display any
oxidative stress and apoptosis even in the presence of external
oxidative stress. The results are from three separate experiments.
Error bars, SD.
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deficient Hep3B-TR cells were free of oxidative stress as indicated by
a total lack of oxidation of nonfluorescent DCFH-DA in reactive cells
(Fig. 5B, right panel), and they appear healthy under these conditions
when the medium was supplemented with copper/zinc (Fig. 5C). As
expected from these observations, they displayed no sign of apoptosis
(data not shown).
The ability of Hep3B-TR cells to tolerate selenium deficiency
prompted us to compare their survival capacity to that of Huh7 cells.
As shown in Fig. 5D, selenium-deficient Hep3B-TR cells survived
under these conditions for at least 10 days (longest time tested), at
which time virtually no Huh7 cells were alive.
In addition, we examined the activation of AKT a downstream
component of the phosphatidylinositol 3-kinase (PI3K) pathway,
which is important in regulating cell survival and apoptosis and which
influences cell survival on oxidative injury (36). AKT protein levels
were viewed by Western blot analysis under selenium-deficient or
-supplemented conditions with Huh7 and Hep3B-TR cells. We ob-
served no difference in either unphosphorylated or active phospho-
rylated AKT protein levels in these apoptosis-sensitive (Huh7) and
apoptosis-resistant (Hep3B-TR) cell lines (data not shown). In addi-
tion to our observations with DCFH assay our data with AKT protein
status indirectly indicates that under selenium-deficient conditions,
resistant Hep3B-TR cells do not display oxidative stress.
Taken together, our observations with Hep3B-TR cells provided
strong evidence that these cells tolerate selenium deficiency. It ap-
peared that these malignant cells have acquired a capacity to survive
and proliferate under long periods of selenium deficiency. This ca-
pacity is accompanied by and probably attributable to their high
tolerance to ROS, as evidenced by our H2O2 treatment studies. It is
expected that the metabolic activity of these cells that is maintained
under selenium-deficient conditions will continue to produce ROS in
their mitochondria. The lack of oxidative stress under these condi-
tions, even in the presence of an excess of H2O2, clearly indicates that
they adapted themselves to eliminate such reactive species by seleni-
um-independent means. This capacity provides them a selective abil-
ity for survival under selenium-deficient and oxidative stress condi-
tions.
Rescue of Selenium-Deficient Huh7 Cells from Oxidative Stress
and Cell Death with Vitamin E. Vitamin E has a protective scav-
enger effect against free-radical damage. In the presence of metal
ions, hydroxyl radical (HO•) is produced from H2O2. Vitamin E that
is integrated in cellular membranes has been shown to reduce HO•
and, in this way, protects peroxidation of lipids (37). Because sele-
nium deficiency leads to the accumulation of ROS as evidenced by the
DCFH assay in Huh7 cells leading to apoptosis (Fig. 1B), we wanted
to test whether Vitamin E has a protective scavenger effect on sele-
nium deficiency-induced oxidative stress and the apoptosis in Huh7
cells. Indeed, as shown in Fig. 6, Vitamin E has a protective antiox-
idant effect on selenium deficiency-induced ROS. As a consequence,
we observed neither the oxidative stress nor the apoptosis in Huh7
cells in the presence of Vitamin E under selenium-deficient condi-
tions. Vitamin E had an indifferent effect on Hep3B-TR cells under
the same conditions, because we did not observe any oxidative stress
(data not shown).
Most Hepatocarcinoma Cell Lines Tolerate Selenium Defi-
ciency. Contrasting abilities of two HCC cell lines to survive under
selenium-deficient conditions led us to extend our investigations to
other hepatocellular cancer cell lines. Twelve HCC-derived and one
hepatoblastoma-derived cell lines were tested. All but three cell lines
were able to survive under selenium-deficient conditions, in a way
quite similar to the Hep3B-TR cell line (experimental data not shown;
see Table 1 for a summary). In total, 10 (77%) of 13 cell lines
tolerated selenium deficiency. Included in this tolerant group was the
Hep3B cell line from which Hep3B-TR was derived. In addition to
Huh7, HCC-derived Hep40 and hepatoblastoma-derived HepG2 cell
lines died by apoptosis under selenium deficiency (data not shown for
Hep40; see Figs. 7–9 for HepG2). It is noteworthy that only one
(33%) of these three sensitive cell lines had integrated HBV se-
quences in its genome. In contrast, 9 (90%) of 10 tolerant cell lines
displayed integrated HBV sequences, indicating past exposure to this
virus. Keeping in mind that both selenium deficiency and HBV
infection have a synergic effect on HCC risk (18), the association of
tolerance to selenium deficiency with a history of HBV infection
suggested to us that these two could be related. For example, selenium
deficiency could favor the risk of HBV infection. Alternatively, HBV
infection could facilitate the ability of malignant cells to gain toler-
ance to selenium deficiency.
Fig. 5. Analysis of Hep3B-TR cells under selenium-supplemented and selenium-
deficient conditions. Hep3B-TR cells were grown in selenium-supplemented (Se) or
selenium-deficient (Se) conditions. A, in vitro selenium deficiency of Hep3B-TR cells
in DMEM was tested by the loss of Gpx activity. At 96 h, cells were solubilized, and equal
amounts of soluble proteins from cell lysates were separated by native PAGE, followed
by in situ staining for Gpx with a colorimetric assay. B, analysis of oxidative stress by
oxidant-sensitive fluorescent dye, DCFH-DA. Hep3B-TR cells were cultured under sele-
nium-deficient (Se) HAM’s medium for 96 h. Hep3B-TR cells did not exhibit a positive
fluorescent signal, indicating that, unlike Huh7 cells (Fig. 1B), they do not harbor
oxidative stress (right). Light microscopy photographs of the corresponding area of
fluorescent photographs of Hep3B-TR cells under selenium-deficient (Se) conditions
were also shown (left). 200. C, Hep3B-TR cells grown in a selenium-supplemented
(Se) or selenium-deficient (Se) HAM’s medium, examined under light microscope on
a daily basis, with pictures taken at day 5. 100. D, comparison of the survival of
HBV-negative Huh7 and HBV-positive Hep3B-TR cells. Cell lines were cultured under
selenium-supplemented (Se) and selenium-deficient (Se) DMEM cell culture for 10
days, and attached cells were visualized by Giemsa staining. Whereas Hep3B-TR cells
were able to expand under selenium-deficient conditions, Huh7 cells did not survive.
Survival of the both cell lines was not affected under selenium-supplemented conditions.
100.
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HBV Confers Tolerance to Selenium Deficiency in HepG2
Cells. To test whether the introduction of HBV into malignant cells is
associated with acquired tolerance to selenium deficiency, we took
advantage of the availability of the HBV-transfected 2.2.15 clone of
the HepG2 cell line that produces infectious HBV virions (38). First,
these two isogenic cell lines were cultivated under selenium-deficient
and selenium-supplemented conditions for 10 days. Both cell lines
showed similar growth rates under selenium-supplemented condi-
tions. However, their responses to selenium deficiency were different.
As reported in Table 1, parental HepG2 cells were sensitive to
selenium deficiency, whereas the 2.2.15 clone was tolerant. This
acquired tolerance was accompanied with the following changes in
2.2.15 clone cells. When exposed to 200 M H2O2, under selenium
deficiency, the 2.2.15 clone, but not the parental HepG2 cells, re-
sponded with a lack of progressive oxidative stress that was associated
with a lack of cell death (Fig. 7). Accordingly, selenium deficiency in
the HepG2 cell line resulted in the accumulation of cells with oxida-
tive stress in selenium-deficient copper/zinc-containing HAM’s me-
dium (Fig. 8). The release of cytochrome c from mitochondria (Fig.
9A, bottom right panels), and apoptosis (Fig. 9B) were also observed
in the HepG2 cell line (as in the case of the Huh7 cell line) but not in
the HepG2-2.2.15 cell line. The 2.2.15 clone resisted selenium defi-
ciency, so that the effects of selenium starvation observed in the
parental HepG2 were no longer detectable in the cells of this clone
(Figs. 8 and 9). Moreover, Vitamin E had the same protective anti-
oxidant effect on HepG2 cells under selenium deficiency (data not
shown) as Huh7 cells (Fig. 6). These major differences between
2.2.15 and HepG2 cells were detectable only under selenium-deficient
conditions, because the in vitro survival and proliferation capacities of
the two cell lines did not differ from each other under selenium-
supplemented conditions (data not shown).
DISCUSSION
Despite increasing awareness about the importance of selenium to
human health, its fundamental roles in cell biology remain poorly
understood. Moreover, cellular mechanisms involved in the pathogen-
esis of selenium-deficiency syndromes and the molecular basis of
selenium protection are not well known. Previous studies on selenium
deficiencies relied on in vivo whole animal models, mostly using
rodents (39, 40). Here, we developed an in vitro experimental model
based on human cell lines, rather than rodent tissues, so that biological
responses may be a better representation of related changes in hu-
mans. In addition, in vitro models are easy to perform, allow a better
control of selenium supply, and provide clear-cut end results because
of the homogeneity of the cell populations studied. Finally, cell lines
are readily available for in vitro modifications to change experimental
parameters. The caveat is that the extrapolation of in vitro observa-
tions to in vivo situations requires extreme care and prudence. With
these considerations in mind, we believe that our findings provide
some insights on selenium deficiency and its implications in hepato-
cellular malignancy in human.
It has been known for a long time that rats that are fed with a
selenium-deficient diet develop so called dietary “necrotic” liver
degeneration (see Ref. 8). Although in vivo hepatic response to
selenium deficiency has not been characterized specifically as apo-
ptotic cell death, it is now well established that selenium deficiency
causes oxidative stress (see Refs. 1 and 2), and apoptosis is a common
cellular response to oxidative stress (41). Our extensive observations
with Huh7 and HepG2 indicate that these “hepatocyte-like” malignant
cells undergo a delayed apoptotic cell death that is detectable after
3–4 days of culture in a selenium-deficient medium. This apoptotic
response is associated with the depletion of Gpx activity in the cells
and correlates with oxidative stress and the release of cytochrome c
from the mitochondria, in a time-dependent manner. The depletion of
selenium-dependent Gpxs, which act as antiapoptotic factors under
oxidative stress by catalyzing the reduction of phospholipid hydroper-
oxides as well as hydrogen peroxide (42), may contribute to apoptosis
induced by selenium deficiency in our cell lines. There are several
studies demonstrating that H2O2 leads to the release of cytochrome c
from the electron transport chain, consequently from mitochondria to
cytoplasm leading to apoptosis (43–46). In the absence of the sele-
nium-dependent Gpx activity, H2O2, which is produced from a su-
peroxide radical by superoxide dismutase enzyme, is converted to a
hydroxyl radical (HO•) by ferrous (Fe2) iron-dependent Fenton’s
reaction. The release of cytochrome c from mitochondria has been
previously linked to the peroxidation of cardiolipin, a mitochondrion-
membrane-specific phospholipid, by ROS (42, 47). In our study, we
also support this mechanism by preventing cell death in selenium
deficiency-induced apoptosis-sensitive Huh7 and HepG2 cell lines
with Vitamin E, which is incorporated into cellular membranes as a
potent scavenger of HO• . In the absence of a ROS scavenger such as
Table 1 Tolerance of HCCs to in vitro selenium deficiency







SNU 475 Yes Yes
SNU 449 Yes Yes
SNU 423 Yes Yes
SNU 387 Yes Yes
SNU 182 Yes Yes
PLC/PRF/5 Yes Yes Aflatoxinsb
Mahlavu Yes No Aflatoxinsb
a Presence of HBV DNA was tested by PCR amplification, as described previously
(17). HBV status of these cell lines has been reported previously (58, 59).
b Cell line displaying p53-codon 249 mutation that has been associated to aflatoxin
exposure (50, 51).
Fig. 6. Resistance of Huh7 cells to selenium deficiency-induced oxidative stress with
vitamin E. Huh7 cells were cultured under selenium-deficient (Se) DMEM that con-
tained a total of 100 M vitamin E for 72 h (on the first day, 50 M and, on the second
and third days, 25 M Vitamin E was added to culture medium) then tested for oxidative
stress by oxidant-sensitive fluorescent dye DCFH-DA under an inverted fluorescent
microscope. Huh7 cells harbor oxidative stress (black arrows) and apoptosis (white
arrows) in the absence of vitamin E (bottom left panel). Absence of fluorescence in the
presence of vitamin E (bottom right panel) indicates that Huh7 cells have acquired
resistance to oxidative stress. Inverted light microscopy photographs (top panels) of the
corresponding area of fluorescent photographs of Huh7 cells under Se conditions are
also shown. Notable is the absence of cell death in Se medium supplemented with
vitamin E (right panels). 200.
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Vitamin E under selenium deficiency, accumulated ROS, as illus-
trated by the observations with Huh7 and HepG2 cell lines, may have
an effect on the peroxidation of cardiolipin leading to the release
of cytochrome c. Cytoplasmic cytochrome c is the immediate trigger
of apoptosis via activation of caspase 9, followed by activation of
caspase 3, as evidenced here by the degradation of PARP, a known
substrate for caspase 3 (34). On the other hand, the apoptotic response
observed here is p53 independent because of the fact that this gene is
mutated in Huh7 cells (48).
The second, but probably the most challenging, of our observations
is that a large group of HCC cell lines [10 (77%) of 13] tolerate
selenium deficiency. Malignant cells belonging to this group are able
to survive and keep their proliferative capacity for a long period (at
least 10 days in culture) under selenium-deficient conditions. As
illustrated by the observations with Hep3B-TR cell lines from this
group, the in vitro survival of HCC cells under selenium deficiency
depends on their ability to counteract oxidative stress-generating
ROS, as evidenced by their resistance to oxidative stress challenge by
exogenously supplied H2O2. Because they do not display a positive
reaction with an oxidative stress indicator and they do not release
cytochrome c from their mitochondria under selenium deficiency, it is
highly likely that these HCC cells are also able to counteract meta-
bolically generated ROS during mitochondrial respiration (see Ref.
49). Moreover the fact that apoptosis-sensitive Huh7 and HepG2 cells
became resistant to selenium deficiency in the presence of Vitamin E
demonstrates that these malignant cells adapt by a mechanism to
scavenge ROS produced by electron transport chain in the absence of
selenium. This adaptation could not be explained by a slow rate of
proliferation, because the proliferation rates of these cell lines are not
affected under selenium-deficient conditions when compared with
their growth in selenium-supplemented conditions, even though they
grow much better in 10% FCS-containing medium (data not shown).
Our studies with HepG2-derived 2.2.15 clone indicate that the
Fig. 7. Tolerance of HBV-positive 2.2.15 clone of
HepG2 cells to selenium deficiency and oxidative stress.
HepG2 and 2.2.15 cells were cultured under selenium-
supplemented (Se) and selenium-deficient (Se) DMEM
for 72 h and were treated with the indicated concentrations
of H2O2. Four h later, cells under oxidative stress were
counted under a fluorescent microscope, and apoptotic
cells were counted by Hoechst 33258 staining. With in-
creasing concentrations of H2O2, the percentage of HBV-
negative HepG2 cells under oxidative stress and apoptosis
increased accordingly. However, HBV-positive HepG2-
2.2.15 cells did not display oxidative stress even in
the presence of external oxidative stress source H2O2.
The results are from three separate experiments. Error
bars, SD.
Fig. 8. Analysis of oxidative stress in HepG2-2.2.15 cells under selenium deficiency.
HepG2 and 2.2.15 cells were cultured under selenium-deficient (Se) HAM’s medium for
72 h. DCF fluorescence as an indicator of oxidative stress was observed under an inverted
fluorescent microscope. HepG2 cells harbored oxidative stress (black arrows) and apop-
tosis (white arrows), whereas 2.2.15 cells did not. 200.
Fig. 9. Apoptosis as a result of oxidative stress in HepG2 cells but not in HepG2-2.2.15
cells. A, immunostaining of cytochrome c protein under selenium-supplemented (Se)
and selenium-deficient (Se) conditions. Under selenium-supplemented conditions,
HepG2 and HepG2-2.2.15 cells show punctuate mitochondrial cytochrome c stain. HepG2
cells, but not HepG2-2.2.15 cells, showed diffuse cytoplasmic cytochrome c stains (white
arrows) under selenium-deficient conditions. Corresponding nuclei of all cells were
counterstained with Hoechst 33258. Notable are the condensed nuclei of HepG2 cells that
release cytochrome c. B, HepG2 and HepG2-2.2.15 cells were compared by fluorescent
NAPO immunostaining. Nuclear DNA was visualized by Hoechst 33258 counterstaining.
HepG2-2.2.15 cells were negative for the assay, indicating that unlike HepG2 cells, they
did not enter apoptosis under selenium-deficient conditions.
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tolerance of HCC cells to selenium deficiency is an acquired capa-
bility. Because selenium is an essential nutrient in animals, our normal
cells cannot tolerate selenium deficiency under normal physiological
conditions. Therefore, it would not be surprising that tolerance to
selenium deficiency is an acquired capability of these malignant cells.
It is interesting to note that, this tolerance correlates closely with the
presence of HBV sequences in the genomes of these cells. The
tolerance displayed by an HBV-positive HepG2-2.2.15 clone of the
sensitive HepG2 cell line may provide additional evidence that this
virus may contribute to the tolerance to selenium deficiency.
Presently, it is unclear whether 10 HCC cell lines (Table 1) have
acquired their tolerance to selenium deficiency in vivo or after in vitro
establishment. It is tempting to speculate that this occurred in vivo at
least in some cell lines. Of these 10 cell lines, 9 have integrated HBV
sequences in their genomes, and the remaining cell line displays an
aflatoxin-related p53 mutation (codon 249; G3T; Refs. 50 and 51).
These aberrations can be considered genetic fingerprints of past
exposure of respective patients to these agents. Both chronic HBV
infection and aflatoxin exposure are known to induce ROS in hepa-
tocytes (52–54). Oxidative stress is considered to play an important
role in liver malignancy (55). Because both selenium depletion and
the excess of ROS are common in chronic liver diseases serving as a
reservoir for hepatic malignancies (6, 20, 56, 57), we cannot dismiss
the possibility that the acquired tolerance of HCC cells to selenium
deficiency and ROS may occur in vivo. Acquired tolerance to sele-
nium deficiency-induced ROS may not be restricted to past exposure
of HCC patients to viral or aflatoxin exposures. Oxidative stress
because of selenium deficiency may play an important role not only in
liver cancer but also in other malignancies. Finally we wanted to
extend our study to cell lines of other cancer types. We tested a total
of 27 different cancer cell lines (breast, 14; colon, 10; melanoma, 3).
We found that 11 of 14 breast cancer cell lines, 8 of 10 colon cancer
cell lines, and all of 3 melanoma cell lines were resistant to selenium
deficiency-induced cell death. Our preliminary data may suggest that
escape from deadly consequences of selenium deficiency may play a
role in other cancer types. In addition, it brings new insight to the
scientific debate on dietary selenium supplementation for cancer pa-
tients, which may eventually be further investigated.
Independent of their causes, the tolerance of most HCC cell lines to
selenium deficiency and ROS provides them a “cryptic survivor
phenotype.” We call it “cryptic” because this phenotype is not ex-
pressed under normal culture conditions, and this is probably why it
remained unnoticed until now. This phenotype could provide a novel
survival mechanism for a subset of HCCs.
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